相关实验视频

Updated: Jun 17, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

在肝细胞癌中NLRC5的表达和临床意义

Xiangyu Ma¹, Shangkun Ning¹, Tong Sun¹

¹Department of Interventional Surgical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Cancer biology & therapy

|August 12, 2024

概括

在肝细胞癌 (HCC) 中高NLRC5表达与患者存活率较差和免疫逃逸率增加相关. 这一发现表明NLRC5是HCC的潜在生物标志物和治疗标.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

核酸结合和寡合化域 (NOD) 类似受体 (NLR) 家庭成员5 (NLRC5) 参与免疫调节和慢性炎症.
在肝细胞癌 (HCC) 发病过程中NLRC5的特定作用仍然不完全理解.

研究的目的:

为了研究HCC瘤组织中的NLRC5表达.
为了评估NLRC5在HCC患者的预后意义.
探索在HCC瘤微环境中的NLRC5和免疫分子之间的关联.

主要方法:

免疫组织化学 (IHC) 用于评估100个HCC组织样本中的NLRC5表达.
使用了统计分析,包括千平方测试,COX回归,卡普兰-梅尔生存曲线和ROC曲线分析.
研究了与临床病理因素和免疫标记 (GZMB,CD8α) 的相关性.

主要成果:

在67%的HCC样本中检测到高NLRC5表达,并与增加的瘤数量,卫星结节和囊入侵有关.
在HCC患者中,较高的NLRC5度与总生存率 (OS) 降低显著相关 (HR=1.79,p=0.041).
NLRC5表达与GZMB和CD8α呈阳性关联,表明在HCC免疫逃避中可能发挥作用. 结合NLRC5,瘤数和囊入侵改善了预后预测 (AUC=0.824).

结论:

NLRC5是HCC进展的重要因素,与不良临床结果有关.
NLRC5作为HCC的潜在预后和预测生物标志物.
针对NLRC5可能是HCC治疗的一个有前途的治疗策略.

关键词:

在HCC中,HCC是HCC.在NLRC5中,NLRC5是NLRC5中的一个.预后预后预后瘤免疫逃避瘤免疫逃避瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...